PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Dermatology, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.\', \'Applied Biology, Inc., Irvine, California, USA.\', \'Trichology Unit, Hospital Universitario Ramón y Cajal, Madrid, Spain.\', \'Department of Dermatology and Radiotherapy, São Paulo State University - UNESP, São Paulo, Brazil.\', \'Brown University, Providence, Rhode Island, USA.\', \'Division of Infectious Diseases, Department of Medicine, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1002/ddr.21688
?:doi
?:hasPublicationType
?:journal
  • Drug development research
is ?:pmid of
?:pmid
?:pmid
  • 32412125
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.65
?:rankingScore_hIndex
  • 53
is ?:relation_isRelatedTo_publication of
?:title
  • Androgen sensitivity gateway to COVID-19 disease severity.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all